CAS RN 152459-95-5
Imatinib, Mikromol™
Descubrir Mikromol - su fuente confiable de estándares de referencia farmacéuticos de alta calidad. Apoyando un análisis preciso y conforme con las normas ISO Materiales acreditados 17034 diseñados para brindar confianza en cada resultado.
Imatinib, TRC
CAS: 152459-95-5 Fórmula molecular: C29 H31 N7 O Peso molecular (g/mol): 493.6 Sinónimo: Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-,4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide,4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide,CGP 57148,Genfatinib,Imatinib Nombre IUPAC: 4-[(4-metilpiperazina-1-il)metil]-N-[4-metil-3-[(4-piridina-3-ilpirimidina-2-il)amino]fenilbenzamida SMILES: CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1
Imatinib, MedChemExpress
MedChemExpress Imatinib (STI571) is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity. Imatinib (STI571) works by binding close to the ATP binding site, locking it in a closed or self-inhibited conformation, therefore inhibiting the enzyme activity of the protein semicompetitively. Imatinib also is an inhibitor of SARS-CoV and MERS-CoV.